SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015846
Filing Date
2020-08-14
Accepted
2020-08-14 16:16:17
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 550662
2 ex10-1.htm EX-10.1 54601
3 ex10-2.htm EX-10.2 26308
4 ex10-3.htm EX-10.3 186113
5 ex31-1.htm EX-31 15975
6 ex31-2.htm EX-31 16516
7 ex32.htm EX-32 8539
  Complete submission text file 0001493152-20-015846.txt   4030314

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE age-20200630.xml EX-101.INS 702881
9 XBRL SCHEMA FILE age-20200630.xsd EX-101.SCH 40536
10 XBRL CALCULATION FILE age-20200630_cal.xml EX-101.CAL 62881
11 XBRL DEFINITION FILE age-20200630_def.xml EX-101.DEF 178660
12 XBRL LABEL FILE age-20200630_lab.xml EX-101.LAB 288537
13 XBRL PRESENTATION FILE age-20200630_pre.xml EX-101.PRE 254770
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 201105281
SIC: 2834 Pharmaceutical Preparations